WVE-006 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses St
Phase 1/2 · Alpha-1 Antitrypsin Deficiency |
WVE Wave Life Sciences Ltd. | WVE-006 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|